| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 12.8× | −1.8× | |
| Price / Book | 1.0× | 2.1× | |
| Price / Sales | 0.3× | 4.0× | |
| Price / Free cash flow | 6.7× | −1.6× | |
| EV / EBITDA | 6.6× | −1.2× | |
| Earnings yield | 7.8% | −14.1% | |
| Free cash flow yield | 14.8% | −9.6% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,275.97 | −2.35% | $1.2T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $262.95 | −1.74% | $633B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $285.70 | +0.18% | $504.87B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $422.86 | −0.50% | $379.56B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.61 | −1.79% | $356.78B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.97 | −3.39% | $272.04B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $171.24 | −0.77% | $265.58B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $668.22 | −1.23% | $247.07B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $441.58 | −1.27% | $238.73B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $157.22 | +0.02% | $194.95B | 22.9× | 37.5% | +26.7% |
